Navigo Proteins discovers and develops novel scaffold proteins-based affinity ligands for commercial biologics GMP purification or as biopharmaceutical drugs/binders. They are all small, stable, highly engineerable, selective, and economically, homogeneously producible.
In PRECISION CAPTURING a protein A-like scaffold serves for an antibody-like capture step even of non-Fc bearing molecules.
In PRECISION TARGETING human ubiquitin is the basis for highly selective Affilin® ligands as part of a broad range of biopharmaceutical drugs.
Navigo Proteins’ unique protein engineering expertise is the basis a world-wide unique, versatile scaffold proteins platform. Our robust, rapid and reliable high-throughput-based, robotics assisted platform designs, produces, analyzes and selects suitable affinity ligand proteins, optimized for their tasks in industrial downstream processing or as biopharmaceutical drugs.
PRECISION CAPTURING creates custom ligands against any biologic, Fc-independent, and enables antibody-like affinity downstream processes, with competitive binding capacities, caustic stabilities, usage-cycles, flow rates and commercially available off-the-shelf leaching assays. It is applicable for purifying any recombinant protein, mAb, virus, VLP, cell, etc.
Navigo Proteins has established partnerships worldwide to convert its custom affinity ligands into ready-to-use, GMP-compliant affinity resins for commercial downstream processing.
Our PRECISION TARGETING platform creates tailored ligands which bind any desired biologic in biopharmaceutical or in diagnostic use, e.g. radiopharmaceuticals, Protein-drug-conjugates, CAR-T ligands or theranostics, in which the same Affilin® binder is employed in diagnosis, treatment and treatment-monitoring.
Navigo Proteins is about 70 heads strong, steadily growing and based in Halle, S/W of Berlin. We offer our expertise to interested pharma, biotech and life sciences companies.
https://www.navigo-proteins.com/imprint
Company Details
- Employees
- 51
- Founded
- -
- Address
- Heinrich-Damerow-Str. 1, Halle/saale,06120,germany
- Phone
- +49 345 27996-330
- in****@****ins.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- navigo-proteins.com
- Keywords
- Protein Engineering, Affinity Chromatography, Downstream Processing, Protein-Drug-Conjugates, target specific delivery, Radiopharmaceuticals.
- HQ
- Halle/Saale
Navigo Proteins Gmbh Questions
Navigo Proteins Gmbh's helpline number is +49 345 27996-330
Navigo Proteins Gmbh's website is navigo-proteins.com
Navigo Proteins Gmbh's LinkedIn profile is https://de.linkedin.com/company/navigo-proteins-gmbh
Navigo Proteins Gmbh has
51 employees.
View email and phone details for 51
employees at Navigo Proteins Gmbh.
Navigo Proteins Gmbh's industry is
Biotechnology Research
Navigo Proteins Gmbh's top competitors are
Evoenzyme,
Priavoid Gmbh,
C-Lecta Gmbh,
Ew Biotech,
Probiogen Ag,
Verovaccines Gmbh,
Icon Genetics Gmbh,
Numaferm,
Veraxa Biotech,
Evotec.
Navigo Proteins Gmbh's support email address is info@navigo-proteins.com
Navigo Proteins Gmbh's categories are Biotechnology Research
Navigo Proteins Gmbh's founding year is 2017
